"Interferon Inducers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons.
| Descriptor ID |
D007369
|
| MeSH Number(s) |
D27.505.696.477.828
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Interferon Inducers".
Below are MeSH descriptors whose meaning is more specific than "Interferon Inducers".
This graph shows the total number of publications written about "Interferon Inducers" by people in this website by year, and whether "Interferon Inducers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Interferon Inducers" by people in Profiles.
-
COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence. Minerva Med. 2021 Feb; 112(1):144-152.
-
Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-ß and IFN inducer. J Infect. 2020 10; 81(4):e1-e10.
-
Advances and challenges in the prevention and treatment of COVID-19. Int J Med Sci. 2020; 17(12):1803-1810.
-
Virus-like infection induces human ß cell dedifferentiation. JCI Insight. 2018 02 08; 3(3).
-
Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model. Antiviral Res. 2017 Mar; 139:1-12.
-
Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia. 2012 Oct; 60(10):1555-66.
-
[Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome]. Antibiot Khimioter. 2011; 56(9-10):41-6.
-
Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice. Antivir Chem Chemother. 2010 Mar 09; 20(4):169-77.
-
Induction of interferon in human leukocyte cultures by natural pathogenic respiratory viruses. J Interferon Res. 1993 Dec; 13(6):423-6.
-
Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J Virol. 1992 Feb; 66(2):743-9.